Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study to Assess the Safety and Effectiveness of the OnePoint Dialysis CannulaTM as a Single-Site Vascular Access Device for Hemodialysis Procedures

NCT07599085 is registered in ClinicalTrials.gov with Evolve Medicus, Inc. as lead sponsor.

NCT NCT07599085
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07599085 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study to Assess the Safety and Effectiveness of the OnePoint Dialysis CannulaTM as a Single-Site Vascular Access Device for Hemodialysis Procedures
Lead sponsor
Evolve Medicus, Inc.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
August 31, 2027
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

vascular access